Effects of 17 Beta-estradiol on the Expression of Interstitial Collagenases-8 and -13 (MMP-8 and MMP-13) and Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) in Ovariectomized Rat Osteoblastic Cells

Overview

Journal J Mol Histol

Specialty Biochemistry

Date 2004 Dec 21

PMID 15609084

Citations 9

Authors

Jian Li

Er-Yuan Liao

Ru-Chun Dai

Qi-You Wei

Xiang-Hang Luo

Affiliations

Soon will be listed here.

Abstract

Estrogen plays an important role in maintaining normal bone metabolism via the direct or indirect regulation of bone cells. Osteoblastic cells, as the target cells of estrogen, can secrete multiple matrix metalloproteinases (MMPs) that participate in bone remodeling. It has been demonstrated that bone loss induced by estrogen deficiency is closely related to the abnormal expression of multiple MMPs in osteoblastic cells. However, the regulating action of estrogen on the expression of interstitial collagenases MMP-8 and MMP-13 in osteoblastic cells in vivo remains unclear. We used an ovariectomized osteoporotic rat model to analyze the changes in the histomorphometric parameters of bone after and without treatment with 17beta-estradiol (E(2)); We also used immunohistochemistry and in situ hybridization to observe changes in the expression of mRNA and the proteins MMP-8, MMP-13 and TIMP-1 in osteoblastic cells in rat proximal tibia. In this study, we found that in the ovariectomized rat the expression of MMP-13 mRNA and protein increased markedly, whereas the expression of MMP-8 and TIMP-1 mRNA and protein did not change significantly. Our analysis showed that the expression of MMP-13 protein was correlated positively to bone trabecular separation, osteoid surface area, and negatively to trabecular numbers and the percentage of trabecula bone volume/total tissue volume. Our results suggest that MMP-13 plays an important role in estrogen deficiency-induced bone loss, while estrogen can inhibit bone resorption and reduce bone turnover rate by down-regulating the expression of MMP-13 in osteoblastic cells.

Citing Articles

Mmp13 deletion in mesenchymal cells increases bone mass and may attenuate the cortical bone loss caused by estrogen deficiency.

Ponte F, Kim H, Warren A, Iyer S, Han L, Mannen E Sci Rep. 2022; 12(1):10257.

PMID: 35715555 PMC: 9205908. DOI: 10.1038/s41598-022-14470-w.

Dynamic expression of matrix metalloproteinases 2, 9 and 13 in ovariectomy-induced osteoporosis rats.

Zheng X, Zhang Y, Guo S, Zhang W, Wang J, Lin Y Exp Ther Med. 2018; 16(3):1807-1813.

PMID: 30186405 PMC: 6122388. DOI: 10.3892/etm.2018.6356.

The Quest for Osteoporosis Mechanisms and Rational Therapies: How Far We've Come, How Much Further We Need to Go.

Manolagas S J Bone Miner Res. 2018; 33(3):371-385.

PMID: 29405383 PMC: 6816306. DOI: 10.1002/jbmr.3400.

Matrix metalloproteinase collagenolysis in health and disease.

Amar S, Smith L, Fields G Biochim Biophys Acta Mol Cell Res. 2017; 1864(11 Pt A):1940-1951.

PMID: 28456643 PMC: 5605394. DOI: 10.1016/j.bbamcr.2017.04.015.

Estrogen receptor antagonism exacerbates cardiac structural and functional remodeling in female rats.

El Hajj M, Ninh V, El Hajj E, Bradley J, Gardner J Am J Physiol Heart Circ Physiol. 2016; 312(1):H98-H105.

PMID: 27769996 PMC: 5283916. DOI: 10.1152/ajpheart.00348.2016.

References

Pustovrh C, Jawerbaum A, Sinner D, Pesaresi M, Baier M, Micone P . Membrane-type matrix metalloproteinase-9 activity in placental tissue from patients with pre-existing and gestational diabetes mellitus. Reprod Fertil Dev. 2001; 12(5-6):269-75. DOI: 10.1071/rd00078. View

Massi D, Franchi A, Ketabchi S, Paglierani M, Pimpinelli N, Santucci M . Expression and prognostic significance of matrix metalloproteinases and their tissue inhibitors in primary neuroendocrine carcinoma of the skin. Hum Pathol. 2003; 34(1):80-8. DOI: 10.1053/hupa.2003.51. View

Liao E, Luo X . Effects of 17beta-estradiol on the expression of matrix metalloproteinase-1, -2 and tissue inhibitor of metalloproteinase-1 in human osteoblast-like cell cultures. Endocrine. 2002; 15(3):291-5. DOI: 10.1385/ENDO:15:3:291. View

Dobnig H, Turner R . Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology. 1995; 136(8):3632-8. DOI: 10.1210/endo.136.8.7628403. View

Uchida M, Yamato H, Nagai Y, YAMAGIWA H, Hayami T, Tokunaga K . Parathyroid hormone increases the expression level of matrix metalloproteinase-13 in vivo. J Bone Miner Metab. 2001; 19(4):207-12. DOI: 10.1007/s007740170022. View

Hui W, Rowan A, Cawston T . Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alpha. Ann Rheum Dis. 2001; 60(3):254-61. PMC: 1753584. DOI: 10.1136/ard.60.3.254. View

Uusitalo H, Hiltunen A, Soderstrom M, Aro H, Vuorio E . Expression of cathepsins B, H, K, L, and S and matrix metalloproteinases 9 and 13 during chondrocyte hypertrophy and endochondral ossification in mouse fracture callus. Calcif Tissue Int. 2001; 67(5):382-90. DOI: 10.1007/s002230001152. View

Holliday L, Welgus H, Fliszar C, Veith G, Jeffrey J, Gluck S . Initiation of osteoclast bone resorption by interstitial collagenase. J Biol Chem. 1997; 272(35):22053-8. DOI: 10.1074/jbc.272.35.22053. View

Bodey B, Bodey Jr B, Siegel S, Kaiser H . Matrix metalloproteinase expression in childhood medulloblastomas/primitive neuroectodermal tumors. In Vivo. 2001; 14(5):667-73. View

10.

Erben R . Embedding of bone samples in methylmethacrylate: an improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry. J Histochem Cytochem. 1997; 45(2):307-13. DOI: 10.1177/002215549704500215. View

11.

Hurst P, Palmay R . Matrix metalloproteinases and their endogenous inhibitors during the implantation period in the rat uterus. Reprod Fertil Dev. 2000; 11(7-8):395-402. DOI: 10.1071/rd99021. View

12.

Parfitt A, Drezner M, Glorieux F, Kanis J, MALLUCHE H, Meunier P . Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987; 2(6):595-610. DOI: 10.1002/jbmr.5650020617. View

13.

Sasano Y, Zhu J, Tsubota M, Takahashi I, Onodera K, Mizoguchi I . Gene expression of MMP8 and MMP13 during embryonic development of bone and cartilage in the rat mandible and hind limb. J Histochem Cytochem. 2002; 50(3):325-32. DOI: 10.1177/002215540205000304. View

14.

Panagakos F, Kumar S . Modulation of proteases and their inhibitors in immortal human osteoblast-like cells by tumor necrosis factor-alpha in vitro. Inflammation. 1994; 18(3):243-65. DOI: 10.1007/BF01534267. View

15.

Mizutani A, Sugiyama I, Kuno E, Matsunaga S, Tsukagoshi N . Expression of matrix metalloproteinases during ascorbate-induced differentiation of osteoblastic MC3T3-E1 cells. J Bone Miner Res. 2001; 16(11):2043-9. DOI: 10.1359/jbmr.2001.16.11.2043. View

16.

Barondess D, Singh M, Hendrix S, Nelson D . Radiographic measurements, bone mineral density, and the Singh Index in the proximal femur of white and black postmenopausal women. Dis Mon. 2003; 48(10):637-46. View

17.

Okada Y . Tumor cell-matrix interaction: pericellular matrix degradation and metastasis. Verh Dtsch Ges Pathol. 2001; 84:33-42. View

18.

Chen R, Wong K, Lawton J, Ho F . Antinuclear antibody detection using streptavidin-biotin-peroxidase complex on HEp-2 cell substrate. Asian Pac J Allergy Immunol. 1992; 10(1):19-24. View

19.

Delany A, Jeffrey J, Rydziel S, Canalis E . Cortisol increases interstitial collagenase expression in osteoblasts by post-transcriptional mechanisms. J Biol Chem. 1995; 270(44):26607-12. DOI: 10.1074/jbc.270.44.26607. View

20.

Tsuzaki M, Guyton G, Garrett W, Archambault J, Herzog W, Almekinders L . IL-1 beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells. J Orthop Res. 2003; 21(2):256-64. DOI: 10.1016/S0736-0266(02)00141-9. View